Trials / Completed
CompletedNCT01331707
DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population
DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity (DUTCH PEERS): Randomized Multicenter Trial in All Comers Population Treated Within Eastern NeThErlands-2 (TWENTE-2)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,811 (actual)
- Sponsor
- Foundation of Cardiovascular Research and Education Enschede · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The introduction of drug-eluting stents (DES) in the treatment of coronary artery disease has led to a significant reduction in morbidity but there are further demands on DES performance. Such demands are an optimized performance in very challenging coronary lesions; third generation DES were developed in an effort to further improve DES performance in such challenging lesions. Two CE-certified third generation DES (Resolute Integrity and Promus Element stents) are currently available; there are no data that indicate an advantage of one of these DES over the other.
Conditions
- Acute Coronary Syndrome
- Angina Pectoris
- Angina, Unstable
- Myocardial Infarction
- Coronary Artery Disease
- Coronary Stenosis
- Coronary Restenosis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Resolute Integrity (Zotarolimus-eluting stent) | Third generation drug-eluting stent |
| DEVICE | Promus Element (Everolimus-eluting stent) | Third generation drug-eluting stent |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2012-12-01
- Completion
- 2013-12-01
- First posted
- 2011-04-08
- Last updated
- 2015-07-28
Locations
4 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01331707. Inclusion in this directory is not an endorsement.